Medicare Anti-A β mAb Coverage With Evidence Development (CED) Study

Conditions: Mild Alzheimer ' s Disease; Mild Cognitive Impairment (MCI) Due to Alzheimer ' s Disease Interventions: Drug: Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer ' s Disease Sponsors: Centers for Medicare and Medicaid Services/ Coverage and Analysis Group Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials